BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33538912)

  • 21. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
    Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of High-Dose Intravenous Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent Focal Segmental Glomerulosclerosis: Results of Case Series.
    Demir ME; Uyar M; Merhametsiz O
    Transplant Proc; 2020 Apr; 52(3):843-849. PubMed ID: 32199645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.
    Ingulli E; Tejani A
    Transplantation; 1991 Feb; 51(2):401-5. PubMed ID: 1994534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression.
    Restrepo JM; Torres-Canchala L; Londoño H; Manzi E; Somers MJG
    BMC Nephrol; 2022 Apr; 23(1):131. PubMed ID: 35382760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
    Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
    Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation.
    Maas RJ; Deegens JK; van den Brand JA; Cornelissen EA; Wetzels JF
    BMC Nephrol; 2013 Feb; 14():47. PubMed ID: 23433074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
    Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB
    Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of recurrent focal segmental glomerulosclerosis post-kidney transplantation in Australian and New Zealand children: A retrospective cohort study.
    Francis A; Didsbury M; McCarthy H; Kara T
    Pediatr Transplant; 2018 Aug; 22(5):e13185. PubMed ID: 29676031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts.
    Kandus A; Ponikvar R; Buturović-Ponikvar J; Bren AF; Oblak M; Mlinšek G; Kmetec A; Arnol M
    Ther Apher Dial; 2013 Aug; 17(4):438-43. PubMed ID: 23931886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.
    Kumar J; Shatat IF; Skversky AL; Woroniecki RP; Del Rio M; Perelstein EM; Johnson VL; Mahesh S
    Pediatr Nephrol; 2013 Feb; 28(2):333-8. PubMed ID: 23052653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant.
    Valdivia P; Gonzalez Roncero F; Gentil MA; Jiménez F; Algarra G; Pereira P; Rivera M; Suñer M; Cabello V; Toro J; Mateos J
    Transplant Proc; 2005 Apr; 37(3):1473-4. PubMed ID: 15866644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.
    Matalon A; Markowitz GS; Joseph RE; Cohen DJ; Saal SD; Kaplan B; D'Agati VD; Appel GB
    Clin Nephrol; 2001 Oct; 56(4):271-8. PubMed ID: 11680656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes of Prophylactic and Therapeutic Plasmapheresis in Adult Deceased-Donor Kidney Transplant Recipients With Primary Focal Segmental Glomerulosclerosis.
    Campise M; Favi E; Messa P
    Exp Clin Transplant; 2019 Aug; 17(4):461-469. PubMed ID: 30570457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.
    Hubsch H; Montané B; Abitbol C; Chandar J; Shariatmadar S; Ciancio G; Burke G; Miller J; Strauss J; Zilleruelo G
    Pediatr Nephrol; 2005 Feb; 20(2):210-6. PubMed ID: 15605284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
    Yabu JM; Ho B; Scandling JD; Vincenti F
    Am J Transplant; 2008 Jan; 8(1):222-7. PubMed ID: 17979998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ; Gera M; Amer H; Iqbal CW; Moore TB; Milliner DS; Cosio FG; Larson TS; Stegall MD; Ishitani MB; Gloor JM; Griffin MD
    Transplantation; 2009 Apr; 87(8):1232-9. PubMed ID: 19384172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Focal segmental glomerulosclerosis after renal transplantation in a child with ANCA-associated glomerulonephritis: case report and literature review].
    Rong LP; Chen LZ; Fu Q; Chen WF; Sun LZ; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):936-940. PubMed ID: 27938596
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis.
    Dirim AB; Demir E; Guller N; Safak S; Artan AS; Oto OA; Ozluk Y; Ozturk S; Yazici H; Kalayoglu-Besisik S; Turkmen A
    J Clin Apher; 2022 Aug; 37(4):376-387. PubMed ID: 35535432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.